Pathogenic streptococcal species are responsible for some of the most lethal and prevalent animal and human infections. Previous reports have identified a candidate pathogenicity island (PAI) in two highly virulent clinical isolates of Streptococcus suis type 2, a causative agent of high-mortality streptococcal toxic shock syndrome. This PAI contains a type-IVC secretion system C subgroup (type-IVC secretion system) that is involved in the secretion of unknown pathogenic effectors that are responsible for streptococcal toxic shock syndrome caused by highly virulent strains of S. suis. Both virulence protein B4 and virulence protein D4 were demonstrated to be key components of this type-IVC secretion system. In this study, we identify a new PAI family across 3 streptococcal species; Streptococcus genomic island contains type-IV secretion system, which contains a genomic island type-IVC secretion system and a novel PPIase molecule, SP1. SP1 is shown to interact with a component of innate immunity, peptidoglycan recognition protein (PGLYRP-1) and to perturb the PGLYRP-1-mediated bacteriostatic effect by interacting with protein PGLYRP-1. Our study elucidates a novel mechanism by which bacteria escape by components of the innate immune system by secretion of the SP1 protein in pathogenic Streptococci, which then interacts with PGLYRP-1 from the host. Our results provide potential targets for the development of new antimicrobial drugs against bacteria with resistance to innate host immunity.
, Staphylococcus aureus (Lindsay, Ruzin, Ross, Kurepina, & Novick, 1998) , Streptococcus pneumoniae (Brown, Gilliland, & Holden, 2001) , and Streptococcus suis (Tang et al., 2006) .
In the present study, we focus on three pathogenic species of Streptococcus: S. suis, S. pneumoniae, and Streptococcus agalactiae. S. suis is responsible for a variety of diseases in pigs, including meningitis, septicemia, arthritis, and pneumonia. It is also a severe zoonotic pathogen that has caused occasional cases of meningitis and sepsis in humans (Segura et al., 2014) and several outbreaks of streptococcal toxic shock syndrome (STSS) in China (Tang et al., 2006) . S. pneumoniae is a lethal bacterial pathogen that is the leading cause of community-acquired pneumonia, sepsis, and meningitis, which collectively results in over one million deaths each year worldwide (Krone, van de Groep, Trzciński, Sanders, & Bogaert, 2014; van der Poll & Opal, 2009) and causes approximately 10% of all deaths in children in the first 5 years of life (Okumura & Nizet, 2014) . S. agalactiae is a Lancefield Group B Streptococcus and is the leading cause of meningitis and sepsis in newborns. Additionally, this pathogen is the cause of serious infections in immunocompromised adults. Clinical manifestations of infection include urinary tract and soft tissue infections, as well as life-threatening sepsis and meningitis (Cotton & Rabie, 2012; Chang et al., 2014) .
The ability of some Streptococci to escape the human innate immune response is very complex, and most examples are not well characterized (Okumura & Nizet, 2014) .
In our previous efforts, an 89-kb PAI (89 K PAI)-like structure had been identified in the highly virulent Chinese strain of S. suis serotype 2, 05ZYH335. This 89 K PAI structure included a specific type-IVC secretion system that is common in the genus Streptococcus (Chen et al., 2007; Zhang, Rong, Chen, & Gao, 2012) . It was further demonstrated that virulence protein B1 (VirB1; SSU05_0968), virulence protein B4 (VirB4; SSU05_0969), and virulence protein D4 (VirD4; SSU05_0973) are the minimal key components of the type-IVC secretion system and that VirB4 and VirD4 of the highly virulent Chinese strains are essential for the secretion of several unknown pathogenic effectors responsible for high-mortality STSS caused by the highly virulent strains Zhao et al., 2011) .
In the present study, we evaluated six genomes from these three species of Streptococcus. The results revealed a new PAI family with a structure similar to that of the 89 K PAI in S. suis strain S4GI, which caused the STSS epidemic. This PAI is also characterized by a novel GI-type-IVC secretion system, as well as a novel molecule, SP1 (SSU05_0942; Figure S1 ), that is distributed throughout the genus Streptococcus and may play an important role in bacterial escape from the host innate immune system response. Upon further investigation, we found that the secretion of SP1 depends on this GI-type-IVC secretion system and that SP1 can interact with the innate immunity protein peptidoglycan recognition protein (PGLYRP-1). PGLYRP-1 is mainly present in polymorphonuclear leukocyte granules and is directly bactericidal to both Gram-positive and Gram-negative bacteria (Dziarski & Gupta, 2010; Royet & Dziarski, 2007) . Most importantly, our data suggest that SP1 blocks the bacteriostatic defense function of PGLYRP-1, thus, revealing a hitherto unknown strategy that enables the escape of pathogenic Streptococcus from the innate immune response.
2 | RESULTS
| Distribution and structural features of the S4GI family
In order to resolve the structural features of GIs across the boundaries of different streptococcal subspecies, a study was conducted using the model provided by Vernikos and Parkhill (Vernikos & Parkhill, 2008) .
Sixty-seven streptococcal genomes across 12 different genera found on public databases, including the National Center for Biotechnology Information and Sanger Institute databases, were analyzed and then compared side-by-side using the Artemis Comparison Tool (ACT; Carver et al., 2008) , which enabled genomic alignment and visualization of BLASTN results. Intriguingly, six reference strains in three different genera displayed structurally similar GIs (Table S1 ). The sequence of 15-bp direct repeats from the 3′-end of sequences of the highly conserved ribosome l7/l12 genes are predicted to be involved in the integration of all 15S GIs. To the best of our knowledge, this is the first report of such l7/l12-specific recombination.
Structurally, although the S4GIs share the 15-bp direct repeats in common, they also share variant G + C content with their host bacteria. Large arrays of proven and putative GIs or PAIs from Gram-positive bacteria have generally had a low G + C content, although a few have had higher G + C contents. Among the six reference streptococcal strains, the G + C contents of the S4GIs in S. pneumoniae ATCC700669 and CGSP14, as well as those in S. suis 05ZYH33 and BM407, were significantly lower than the overall G + C content of their hosts. On the other hand, the G + C contents of the S4GIs in S. agalactiae 2603 V/R and NEM316 were higher (Table S1, Figure 1 ).
Moreover, we found that these S4GIs contained mobility genes that (a) encode a site-specific recombinase/integrase downstream of attL and (b) encode a replication initiator located upstream of attR.
Distribution analyses of these S4GIs using bacterial genomes downloaded from GenBank indicated that they were not related to the serotypes of streptococcal subspecies ( Figure S2) . By comparing the genes carried by these S4GIs, the same GI-type-IVC secretion system and a novel protein, SP1, were identified (Table S2 ). These S4GIs were structurally similar to the previously described 89 K PAI, which was found to be specific to the strains of S. suis that caused the STSS epidemic.
| SP1 interacts with PGLYRP-1
To understand the roles of proteins encoded in the 89 K PAI of S. suis serotype 2 in the development of STSS, we focused on SP1 from the 89 K PAI, a molecule of unknown function predicted to be a member of the PPIase family ( Figure Figure S1 ). A human-yeast two-hybrid leukocyte cDNA library was screened using the SP1 protein from strain 05ZYH33 as bait. Clones that grew in the absence of tryptophan, leucine, histidine, and adenine were processed for a β-galactosidase assay; blue colonies were picked; and 13 colonies were selected for further analysis. The nucleotide sequences of the clones from the cDNA library were analyzed, and the full-length sequences were obtained using Vector NTI Advance 11 and a BLAST database homology search (http://www.ncbi.nlm.nih.gov/). These clones were (Figure 2a ).
The blue colonies were lifted onto a filter and measured for β-galactosidase activity using a colony-lift filter assay (Figure 2b ). The yeast twohybrid experiments demonstrated that SP1 bound to PGLYRP-1. We expressed and purified soluble rSP1 and PGLYRP-1 using E. coli and HEK293T cells (Figure 2c ). We further demonstrated that SP1 from six reference streptococcal strains could interact with PGLYRP-1 in a pull-down assay ( Figure 2d ). To predict which domain of SP1 binds
to PGLYRP-1, we constructed pET-32 plasmids harboring SP1 C-terminal truncates that were generated by polymerase chain reaction 
| Extracellular secretion of SP1 depends on type-IVC secretion system transport
It was previously demonstrated by us that deletion of either virD4 or virB4 of the type-IVC secretion system leads to loss of the lethality of the highly virulent S. suis serotype 2 in infected mice (Zhao et al., 2011) . Therefore, it was expected that the type-IVC secretion system induced the transfer of pathogenic effectors. The reactivity bands of SP1 were stronger in the cell of WT strains than ΔvirB4 mutants ( Figure 4a ). This means that out, missing ΔVirB4 will significantly affect the SP1 protein transport from the intracellular to extracellular.
Although SP1 was detected in bacterial culture supernatant, its concentration was significantly higher in the WT strains compared to both ΔvirB4 and ΔvirD4 mutants ( Figure 4b ). The six different Streptococcus strains produce roughly the same amount of SP1 and show roughly the same reduction upon mutation of VirB4 and VirD4. For this reason, we believe that maybe the secretion of SP1 in these six strains of Streptococcus depends on type-IVC secretion system transport to deal with the same concentration PGLYRP-1 under the same culture conditions as used in vitro.
To further determine the SP1 protein concentrations secreted by the different Streptococcus strains are specifically related to corresponding ΔvirB4 and ΔvirD4 mutants, we used excess of anti-SP-1 resin adsorption to the culture supernatant, and followed SP1
were undetectable by ELISA and Western blot (data not shown). These results indicate that both the VirD4 and VirB4 components of the type-IVC secretion system are necessary for the extracellular secretion of SP1, providing further evidence that SP1 can interfere with PGLYRP-1-mediated bacterial killing.
| PGLYRP-1 induced synthesis of sp1 mRNA
Previous research indicates that peptidoglycan recognition proteins rapidly induce high levels of htrA mRNA in WT Bacillus subtilis and cpxP mRNA in WT E. coli by activating regulators via a sensor (Kashyap et al., 2011) . To identify the stress response reaction in PGLYRP-1-treated streptococcal strains, we measured sp1 mRNA levels using quantitative reverse transcription real-time PCR (qRT-PCR). We observed that sp1 mRNA accumulated rapidly in six streptococcal strains during exponential growth, which occurred concomitantly with an increase in sp1 mRNA stability that was proportional to the concentration of PGLYRP-1 in the culture medium ( Figure 5 ).
| DISCUSSION
GIs with structural similarity to the 89 K PAI of S. suis serotype 2, which was responsible for the outbreaks of STSS in China (Tang et al., 2006) , were in six genomes from three species of Streptococcus.
These GIs share two 15-bp direct repeats in two respective attachment sites, attL and attR, of the streptococcal genome, where they integrate in a site-specific manner. GIs often carry genes that confer a selective advantage to the host bacterium in a specific environment (Vernikos & Parkhill, 2008) . This study reveals the presence of genes belonging to the three species of the genus Streptococcus in the six S4GIs, with only a few genes in the S4GIs being found in any single strain or species ( Figure S2 ). However, by comparing protein sequences encoded by genes in all the S4GIs, a range of G + C deviations content could be observed (Table S1 ). In addition, the genomic positions of these GIs were not random. Generally, approximately 75% of currently known GIs are inserted at the 3′-end of a tRNA locus (Vernikos & Parkhill, 2008; Jain, Ramineni, & Parekh, 2011) . A few other genes may also act as integration sites for GIs, such as Salmonella genomic island 1, which exhibits site-specific integration into Salmonella enterica, E. coli, or Proteus mirabilis chromosomes at the 3'-end of the thdF gene (Doublet, Golding, Mulvey, & Cloeckaert, 2008) .
Identification of SP1 inhibition of peptidoglycan recognition protein (PGLYRP-1) antibacterial function. ΔSP1 mutant or wild type was incubated with PGLYRP-1 (100 μg/ml), PGLYRP-1 (100 μg/ml) plus rSP-1 (250 μg/ml), or BSA as a control. Bacterial numbers were determined by colony counts. (a) The dynamic observation of the line graphs or (b)1.5 hr of the histograms indicated that ΔSP1 mutant incubated with PGLYRP-1 and wild type incubated with BSA or PGLYRP-1 (control). Student's t test was used to analyze the statistical differences between the clone number ΔSP1 mutant and wild type. The data represent the means ±SEM of three experiments *, p ≤ .05
The results of analyses performed in the present study indicated that six strains of three species of pathogenic Streptococci comprising S. suis, S. pneumoniae, and S. agalactiae also carried a PAI similar in structure to the 89 K PAI in S. suis serotype 2. Phylogenetic analyses and the distributions of homologous genes revealed no obvious species specificity for the S4GIs. In other words, the genes of the S4GIs have similar sources, except for the basic structure of GIs ( Figures S2 and   S3 ). The most conserved genes located on S4GIs are those for the type-IVC secretion system, a novel gene sp1, as well as the mobility genes often located in GIs (e.g., integrase and replication initiator protein A).
S. suis, S. pneumoniae, and S. agalactiae are known to be highly successful pathogens in both human and animal hosts (Toivanen et al., 2010; Pan, Yang, & Zhang, 2014) . It is well established that bacterial type-IV secretion systems are evolutionarily related to conjugation systems, play a pivotal role in infection, and are vital to bacterial survival (Kubori et al., 2014; Low et al., 2014) . We describe a new PAI family containing a GI-type-IVC secretion system and a sp1 gene that might serve to explain how these three streptococcal species escape from the host immune system. The key components of the system involved in highly pathogenic S. suis type-2 mortality are highly correlated (Skippington & Ragan, 2011) . The GI-type-IVC secretion system is versatile and secretes a wide variety of substrates, from single proteins to protein-protein and protein-DNA complexes in pathogenic bacteria (Zhang et al., 2012) . Protein molecules transported across the bacterial membrane via T4SS include numerous virulence factors (Kubori et al., 2014) , which could play a role in overcoming the host innate immune system. We have demonstrated that SP1 is a secreted protein and is partially dependent on the GI-type-IVC secretion system; more importantly, we further identified that the SP1 protein can interact with the bactericidal innate immunity protein PGLYRP-1.
The bactericidal activity of PGLYRPs depends on its interaction with peptidoglycan found in the cell wall and particularly in cell separation sites where its binding activates the CssR-CssS two-component system, which senses extracytoplasmic misfolded proteins.
CssR-CssS triggers membrane depolarization and [OH]
− production, which results in the inhibition of macromolecule synthesis and 
| EXPERIMENTAL PROCEDURES

| Bacterial strains and growth conditions
Streptococcal strains are listed in Table S3 . All strains were cultured at 37°C on Columbia agar supplemented with 5% sheep's blood or in Todd-Hewitt broth (Difco Laboratories, Shanghai, China) supplemented with 1% yeast extract (THY) or plated on Todd-Hewitt broth agar (1.5%) containing 5% (vol/vol) sheep blood. If required, 100 μg/ ml spectinomycin (Sigma-Aldrich, Shanghai, China), 10 μg/ml tetracycline (Sigma-Aldrich, Shanghai, China), 500 μg/ml kanamycin (Sigma), and 4 μg/ml chloramphenicol (Sigma-Aldrich, Shanghai, China) were added, and streptococcal strains were grown overnight on sheep blood agar plates at 37°C. Isolated colonies were then used as inoculant for 2 ml of THY, which was incubated for 16 hr at 37°C with agitation.
Working cultures were prepared by transferring 50 μl of the 16-hr cultures into 5 ml of THY (1:100 dilution) and allowing them to stand at 37°C for 8 hr. Bacterial yeast strains and plasmids for yeast twohybrid experiments were obtained from Clontech Co., USA. Bacterial strain DH5α was used to clone each shuttle plasmid.
| Bactericidal assay
The bactericidal and bacteriostatic activities of human PGLYRPs were assayed on logarithmically growing bacteria as described previously (Kashyap et al., 2011) . Bacteria were precultured overnight and subcultured for 4 hr in THY. Assay mixtures for antibacterial activities contained 1 × 10 6 colony-forming units of the tested bacteria and PGLYRP-1 or bovine serum albumin (fraction V; Sigma-Aldrich, Shanghai, China) in 1 ml of assay buffer (5 mM Tris-HCl pH 7.6, 150 mM NaCl, 2.5 mM CaCl 2 , 5 μM ZnSO 4 , and 5% glycerol FIGURE 5 sp1 transcription was induced by peptidoglycan recognition protein (PGLYRP-1). sp1 mRNA expression in streptococcal strains incubated with PGLYRP-1 or BSA (100 μg/ml) for 40 min. The data represent the means of four experiments ±SEM, the significance of difference was calculated using the Student's t test, *, p ≤ .05
supplemented with 1% LB broth). Where indicated, 1-mM zinc chloride or 1-mM EDTA was added to the assay mixture. At every 0.5 hr (until 6 hr) after the treatment, 100 μl of the mixture was recovered, and serially diluted specimens were plated on THY agar. Colonies were counted 24 hr later. Neutralization by rabbit anti-PGLYRP-1 polyclonal antibody (Sigma-Aldrich, Shanghai, China) was accomplished by adding 1 mg of the antibody to the mixture.
| Preparation of proteins from the supernatants or whole cells
The protein preparation was similar to our previously published study (Yin et al., 2016) . Briefly, the Streptococcus strains were cultured to the late exponential growth phase and harvested by centrifuge at 10,000×g for 10 min at 4°C. The supernatant proteins precipitation employed trichloroacetic acid in accordance the standard protocols (Sivaraman, Kumar, Jayaraman, & Yu, 1997) . The cell pellets were resuspended in a lysis buffer (50 mM Tris-HCl, 2 mM EDTA, 100 mM NaCl, 0.5% Triton X-100, 10 mg/ml lysozyme, and protease inhibitor cocktail at pH 8.5-9.0) and incubated at 37°C for 4 hr. After disruption was performed with three cycles of alternating ultrasound and freezing/thawing, the lysates were centrifuged at 2,000×g for 5 min to remove debris. The resulting supernatants were collected as whole-cell proteins.
| Sodium dodecyl sulfate (SDS)-PAGE and Western blotting
SDS-PAGE was performed as described before (Osanai et al., 2011) .
For confirmation of the purity of PGLYRP-1, 2 μg of recombinant protein was examined using SDS-PAGE. Protein concentrations were determined using a Bio-Rad protein assay (Bio-Rad, USA) according to the manufacturer's instructions and were normalized to 20 μg/well. 
| Construction of gene deletion mutant strains
The disruption of streptococcal genes was achieved by transformation with PCR amplicons of DNA fragments flanking each target gene and an intervening antibiotic cassette, as previously described. Briefly, the DNA sequences flanking the target gene were amplified from the chromosomal DNA of each strain using PCR with two pairs of specific primers carrying EcoRI/BamHI and PstI/HindIII restriction enzyme sites, respectively. Following digestion with the corresponding restriction enzymes, the DNA fragments were directionally cloned into a pUC18 vector. Then, the Spc R gene cassette (from pSET2) was inserted at the BamHI/PstI sites to generate the target gene knockout vector.
To obtain the isogenic mutant, competent cells were subjected to electrotransformation with pUC:gene, as described previously (Li et al., 2008) . A colony PCR assay was used to examine all Spc R transformants with a series of specific primers.
| Yeast two-hybrid assays
A leukocyte cDNA library was screened as described previously (Lin et al., 2006) . 4.7 | Assay for β-galactosidase activity β-galactosidase activity was determined using a colony-lift filter assay as previously described (Wang, Yuan, & Jiang, 2006) . Briefly, fresh colonies were grown on a plate at 30°C for 4 days until they reached 2-3 mm in diameter. A sterile Whatman #5 filter was placed over the surface of the plate of colonies, and the filter was gently rubbed with the side of the forceps until it was evenly wet. The filter was carefully lifted off the agar plate with forceps and transferred (colonies facing up) to a pool of liquid nitrogen. After the filter had frozen completely (approximately 10 s), it was removed and allowed to thaw at room temperature. The filter was then carefully placed, with the colony side up, on another filter that was presoaked in a clean 90-mm plate containing 3 ml of Z buffer X-gal solution. The filters were incubated at 30°C and checked periodically for the appearance of blue colonies.
| Expression of human PGLYRP-1 and streptococcal SP1
The 
| Sandwich ELISA for detecting SP1 protein
Anti-SP1 monoclonal antibodies were screened for their reactivity to recombinant SP1 protein, and highly reactive anti-SP1 monoclonal antibodies were tested for their suitability for sandwich ELISA. The optimum dilutions of these reagents were selected by checkerboard titration. Next, sandwich ELISA was performed as follows: briefly, 96-well microtiter plates (Nunc, Roskilde, Denmark) were coated with anti-SP1 monoclonal antibody at a suitable concentration and incubated at 4°C overnight. After blocking with nonfat dry milk, recombinant SP1 protein in phosphate-buffered saline was added and incubated for 2 hr at 37°C. Subsequently, the wells were washed four times and incubated with other horseradish peroxidase-conjugated anti-SP1 monoclonal antibodies for 1 hr at 37°C. Finally, after six washes, 3,3′,5,5′-tetramethylbenzidine substrate (Sigma-Aldrich, Shanghai, China) was added to the wells, the plates were incubated for 20 min in the dark, and the absorbance was read at 450 nm after the reaction was stopped with 2.0 N H 2 SO 4 . To generate a standard curve, 1.0 to 1,000 μg/ml of recombinant SP1 protein was used in the sandwich ELISA and the A 450 of the plates was determined using a microplate reader (Thermo Scientific Multiskan GO, USA). The resultant absorbance values were plotted on a graph and fitted to a linear equation, which served as the calibration curve. The detection limit of the assay was defined as the mean value of the blank plus three times its standard deviation.
4.11 | Sandwich ELISA for determining interaction between SP1 and PGLYRP-1 interaction 
| Pull-down assays and dot blots
Anti-SP1-specific affinity resin was covalently linked to agarose using a Co-Immunoprecipitation kit (Thermo Fisher Scientific, Pierce, Shanghai, China). The supernatant proteins (2 mg) from the strains and PGLYRP-1 protein (300 μg) was mixed with 100 μl of anti-SP1 resin slurry (containing approximately 100 μg of coupled SP1-specific IgG) and was incubated overnight at 4°C under constant rotation. The anti-SP1 resin was collected by centrifugation at 1,000 rpm for 2 min and washed three times with IP-lysis/wash buffer (Pierce). The proteins that bound to the anti-SP1 resin were eluted by boiling in SDS sample-loading buffer and were analyzed by SDS-PAGE and Western blotting with a monoclonal antibody against SP1 or a polyclonal anti-PGLYRP-1 antibody produced in mouse or rabbit (Sigma-Aldrich, Shanghai, China) at a 1:2,000 dilution.
The polyvinylidene difluoride membrane was soaked in 100% methanol for 2-3 min, followed by equilibration in 1 × phosphate-buffered saline for 5 min. Dot blotting was performed by adding 10 μl of the SP1 samples (10 μg) to each slot. The membrane was incubated in 5% nonfat dry milk in TBST with rocking for 1 hr at room temperature. The membrane was washed with TBST three times for 10 min.
The membrane was then incubated with PGLYRP-1 (100 μg/ml) for 1 hr with rocking at room temperature. The membrane was washed three times for 10 min with TBST. The appropriate dilution of primary antibody (anti-PGLYRP-1 antibody produced in rabbit [Sigma] at a 1:2,000 dilution) was added, followed by incubation for 1 hr with rocking at room temperature. Again, the membrane was washed three times for 15 min with TBST. The membrane was then incubated in the appropriate dilution of secondary anti-rabbit IgG-HRP antibody for 1 hr with rocking at room temperature, followed by three more washes for 15 min with TBST. After the last washing step, substrate development was performed using an enhanced-chemiluminescence blotting reagent (Roche Diagnostics, Mannheim, Germany) and Kodak film (Kodak, USA).
| Comparative genomics and prediction of GIs
Each genomic sequence comparison was performed using National
Center for Biotechnology Information BLAST, which is available in the BioEdit Sequence Alignment Editor. The results were visualized using ACT release 8, based on Java Web start launcher™. The files of all S4GIs were obtained from GenBank using Vector NTI Advance 11
software. The figures were generated using ACT, and Vector NTI Advance 11 exported graphics (Figure 1 ).
| Identification of genes
Protein sequences from all the S4GIs were compared using BLASTP with matrix BLOSUM62 with the expectation value set at 1.0E-20
and an additional criterion of match length set at 75% of the query sequence.
| Quantitative real-time PCR analysis
The Streptococcus strains were incubated with PGLYRP-1 and albumin (control), and total RNA was extracted using a Qiagen RT kit (Qiagen, USA) according to the manufacturer's instructions. The RNA concentration was evaluated by A260/A280 measurement. The degenerate oligonucleotide primers used for qRT-PCR analysis were designed from Streptococcus genome sequences using Clone Manager Suite 7 (Scientific & Educational Software) and were synthesized by Invitrogen (Shanghai, China). The following primers were used for the qRT-PCR analysis: sense 5′-CGYATYMARCCYTAYATGACDGAHTC-3′ and antisense 5′-ATCWGAHACATARGTYACHTKATARG-3′. qRT-PCR and the data analysis were performed as previously described (Dramsi et al., 2006) . Duplicate reactions were performed using RNA samples isolated from at least two separate assays for each incubation time point. A 453-bp fragment of the recA gene was used as an internal control between streptococcal strains of the three species according to the protocol previously described (Sistek et al., 2012; Florindo et al., 2012) .
| Ethics statement
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